ƒ of IV = 1 by definition, but… [Off Topic]

posted by Darborn – Taiwan, 2024-08-01 14:36 (283 d 14:15 ago) – Posting: # 24120
Views: 2,541

Actually it's not about a bioequivalence study or comparative BA study. It's about two intravenous formulations that one of them has longer half-life hence larger exposure. So I'm just bothered by which one of bioavailability fits this situation by definition, absolute or relative.

BTW, the guideline I refer to is FDA's "Bioavailability Studies Submitted in NDAs or INDs — General Considerations", page 3. :-)


Edit: Please follow the Forum’s Policy. Guidance linked. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
109 visitors (0 registered, 109 guests [including 7 identified bots]).
Forum time: 04:51 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5